Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
More than 1 million individuals in the United States are HIV positive, with greater than 40,000 new patients being diagnosed per year. With the advent of highly active antiretroviral therapy (HAART), HIV-infected patients in the United States are living longer. HIV-infected patients receiving HAART now more commonly have noninfectious and nonopportunistic complications of their disease. This review article will discuss the assessment and treatment of HIV-positive patients in the era of HAART, with an emphasis on the noninfectious and changing infectious complications that require emergency care.
Venkat
Arvind
A
Department of Emergency Medicine, Allegheny General Hospital, Pittsburgh, PA 15212, USA. avenkat@wpahs.org
Piontkowsky
David M
DM
Cooney
Robert R
RR
Srivastava
Adarsh K
AK
Suares
Gregory A
GA
Heidelberger
Cory P
CP
D017088:AIDS-Related Opportunistic Infections / Q000139:chemically induced*; D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000150:complications; D004347:Drug Interactions; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data*; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000150:complications / Q000503:physiopathology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D001523:Mental Disorders / Q000209:etiology*; D009140:Musculoskeletal Diseases / Q000139:chemically induced* / Q000209:etiology; D012307:Risk Factors; D012871:Skin Diseases / Q000139:chemically induced* / Q000150:complications
D044966:Anti-Retroviral Agents